Showing results (131-140 of 365) with videos related to
Sort By:
Pageof 37
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 17, 2023
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2Bernard Tawfik, Zoneddy R Dayao, Ursa Abigail Brown-Glaberman, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2011
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993)Pamela J Atherton, Kelli N Burger, Charles L Loprinzi, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 29, 2007
Levetiracetam for the treatment of hot flashes: a phase II studySusan Thompson, Aditya Bardia, Angelina Tan, et al.Journal of Pain and Symptom Management|February 1, 1997
Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancerS F Chong, M E Bretscher, J A Mailliard, et al.Mayo Clinic Proceedings|October 12, 2004
Pilot evaluation of paroxetine for treating hot flashes in menCharles L Loprinzi, Debra L Barton, Lisa A Carpenter, et al.Mayo Clinic Proceedings|November 6, 2019
Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysisHarry E Fuentes, Robert D McBane, Waldemar E Wysokinski, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 27, 2023
Measuring symptoms and toxicities: a 35-year experienceCharles L Loprinzi, Paul Novotny, Kathryn J Ruddy, et al.Cancer Journal (Sudbury, Mass.)|November 23, 2007
The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanismCharles L Loprinzi, Kami Maddocks-Christianson, Sherry L Wolf, et al.Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.European Journal of Haematology|October 14, 2019
Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trialRobert D McBane, Charles L Loprinzi, Aneel Ashrani, et al.Pageof 37